A healthcare provider can help create a tailored treatment plan that maximizes the advantages of these medications while minimizing potential risks
The challenge is not just losing weight
Cagrilintide is a long-acting analog of amylin, a peptide hormone co-secreted with insulin with broad effects on satiety, gastrointestinal motility, glucagon secretion, bone, muscle, fat, and the cardiovascular system
Clinical trials and real-world data both contribute to our understanding of this topic
GHK-Cu has shown protective effects on cartilage and bone cells in vitro, suggesting potential in joint or bone healing
The SURPASS clinical trial program, which evaluated tirzepatide in over 10,000 patients with type 2 diabetes, included cardiovascular safety assessments